Controversies in the management of ovarian cancer

被引:2
|
作者
Ozols, RF
机构
关键词
cisplatin-cyclophosphamide; cytoreductive surgery; dose intensity; intraperitoneal chemotherapy; new standard chemotherapy; paclitaxel-cisplatin; whole abdomen irradiation;
D O I
10.1046/j.1525-1438.7.s1.4.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A new standard chemotherapy for ovarian cancer has been accepted in the USA: paclitaxel (Taxol(R)) plus a platinum compound (cisplatin or carboplatin). There remain, however, many areas of controversy in treating this disease, including the role of cytoreductive surgery, the optimum combination regimen, the approach to managing patients who achieve a clinical remission, the importance of dose intensity in chemotherapy, the efficacy of intraperitoneal therapy, the benefit of whole-abdomen irradiation, and the status of immunotherapy and hormones.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [31] CURRENT CONTROVERSIES IN THE MANAGEMENT OF TESTICULAR CANCER
    HORWICH, A
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) : 322 - 326
  • [32] Challenges and controversies in the management of penile cancer
    Shabbir, Majid
    Kayes, Oliver
    Minhas, Suks
    NATURE REVIEWS UROLOGY, 2014, 11 (12) : 702 - 711
  • [33] Current controversies in breast cancer management
    Morrow, M
    Jordan, VC
    Takei, H
    Gradishar, WJ
    Pierce, LJ
    CURRENT PROBLEMS IN SURGERY, 1999, 36 (03) : 158 - 216
  • [34] Controversies in the surgical management of rectal cancer
    Kane, JA
    Petrelli, NJ
    SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (04) : 403 - 418
  • [35] Management of rectal cancer: Strategies and controversies
    Jagad, Rajan B.
    Koshariya, Mahim
    Kawamoto, Jun
    Papastratis, P.
    Kefalourous, H.
    Patris, V.
    Tzouma, Christina
    Lygidakis, N. J.
    HEPATO-GASTROENTEROLOGY, 2008, 55 (81) : 82 - 92
  • [36] Controversies in the management of advanced prostate cancer
    Tyrrell, CJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (01) : 146 - 155
  • [37] Contemporary management of ovarian germ cell tumors and remaining controversies
    Veneris, Jennifer Taylor
    Mahajan, Priya
    Frazier, A. Lindsay
    GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 467 - 475
  • [38] Controversies in surgery in ovarian cancer - what is its real role?
    Vergote, I
    EJC SUPPLEMENTS, 2003, 1 (06): : 115 - 125
  • [39] Controversies on the treatment of ovarian cancer with dose-dense chemotherapy
    Suarez-Zaizar, Alberto
    Cardenas-Cardenas, Eduardo
    Araceli Barajas-Castro, Yadira
    Cortes-Esteban, Patricia
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [40] Current controversies in the management of early breast cancer
    L. G. Estévez
    M. Martín
    E. Alba
    R. Colomer
    F. Lobo
    A. Lluch
    E. Adrover
    J. Albanell
    A. Barnadas
    J. García-Mata
    A. Llombart
    M. Muñoz
    C. Rodríguez
    P. Sánchez-Rovira
    M. A. Seguí
    I. Tusquets
    Clinical and Translational Oncology, 2007, 9